82 related articles for article (PubMed ID: 2335127)
1. Limits to genetic intervention in humans: somatic and germline.
Davis BD
Ciba Found Symp; 1990; 149():81-6; discussion 87-92. PubMed ID: 2335127
[TBL] [Abstract][Full Text] [Related]
2. Human gene therapy: scientific and ethical considerations.
Anderson WF
Recomb DNA Tech Bull; 1985 Jun; 8(2):55-63. PubMed ID: 3862183
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy: a status report.
Agarwal S; Khardori R; Khardori N
J Assoc Physicians India; 1992 Feb; 40(2):95-8. PubMed ID: 1629146
[TBL] [Abstract][Full Text] [Related]
4. Germline engineering: the moral challenges.
Engelhardt HT
Am J Med Genet; 2002 Mar; 108(2):169-75. PubMed ID: 11857570
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy. Principles and potential applications.
Amor D
Aust Fam Physician; 2001 Oct; 30(10):953-8. PubMed ID: 11706603
[TBL] [Abstract][Full Text] [Related]
7. [Gene therapy--hopes and fears].
Pietrzyk JJ
Folia Med Cracov; 1998; 39(3-4):131-8. PubMed ID: 10816964
[TBL] [Abstract][Full Text] [Related]
8. [The origin of informed consent].
Mallardi V
Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
[TBL] [Abstract][Full Text] [Related]
9. Somatic gene therapy. Present situation and future perspective.
Gottschalk U; Chan S
Arzneimittelforschung; 1998 Nov; 48(11):1111-20. PubMed ID: 9850435
[TBL] [Abstract][Full Text] [Related]
10. The ethics of human genetic intervention: a postmodern perspective.
Dyer AR
Exp Neurol; 1997 Mar; 144(1):168-72. PubMed ID: 9126167
[TBL] [Abstract][Full Text] [Related]
11. Displaced agendas: current regulatory strategies for germline gene therapy.
Marden E; Nelkin D
McGill Law J; 2000 May; 45(2):461-81. PubMed ID: 12688283
[TBL] [Abstract][Full Text] [Related]
12. Issues of social policy and ethics in gene technology.
Sade RM
Methods Find Exp Clin Pharmacol; 1994 Sep; 16(7):477-89. PubMed ID: 7885073
[TBL] [Abstract][Full Text] [Related]
13. [Gene therapy: ethical aspects and problems of genetic safety].
Zelenin AV
Genetika; 1999 Dec; 35(12):1605-12. PubMed ID: 10687090
[TBL] [Abstract][Full Text] [Related]
14. On the Way to New Horizons: Telemedicine in Oncology.
Schlag PM
Oncologist; 1997; 2(2):III-IV. PubMed ID: 10388041
[TBL] [Abstract][Full Text] [Related]
15. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.
Marx SJ; Agarwal SK; Kester MB; Heppner C; Kim YS; Skarulis MC; James LA; Goldsmith PK; Saggar SK; Park SY; Spiegel AM; Burns AL; Debelenko LV; Zhuang Z; Lubensky IA; Liotta LA; Emmert-Buck MR; Guru SC; Manickam P; Crabtree J; Erdos MR; Collins FS; Chandrasekharappa SC
Recent Prog Horm Res; 1999; 54():397-438; discussion 438-9. PubMed ID: 10548885
[TBL] [Abstract][Full Text] [Related]
16. The new genetic technologies: why a theological perspective is necessary.
Engelhardt HT
Rev Rom Bioet; 2003; 1(1):23-30. PubMed ID: 15011667
[TBL] [Abstract][Full Text] [Related]
17. [Gene therapy].
Zabel B
Monatsschr Kinderheilkd; 1989 May; 137(5):257-61. PubMed ID: 2661996
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial diseases: therapeutic approaches.
DiMauro S; Mancuso M
Biosci Rep; 2007 Jun; 27(1-3):125-37. PubMed ID: 17486439
[TBL] [Abstract][Full Text] [Related]
19. An integrative view of dynamic genomic elements influencing human brain evolution and individual neurodevelopment.
Gericke GS
Med Hypotheses; 2008 Sep; 71(3):360-73. PubMed ID: 18599223
[TBL] [Abstract][Full Text] [Related]
20. Genetic medicines: treatment strategies for hereditary disorders.
O'Connor TP; Crystal RG
Nat Rev Genet; 2006 Apr; 7(4):261-76. PubMed ID: 16543931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
